Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI.
Sarah JesseHans-Peter MüllerHans-Jürgen HuppertzStephanie AndresAlbert C LudolphMichael SchönTobias M BoeckersJan KassubekPublished in: Orphanet journal of rare diseases (2023)
In summary, alterations of neurodegenerative CSF markers in PMS individuals could be demonstrated which were correlated with structural connectivity losses of the corticospinal tract, the splenium, and the dorsal part of the cingulum, which can also be associated with typical clinical symptoms in these patients. These findings might represent a state of dysfunctional processes with ongoing degenerative and regenerative processes or a kind of accelerated aging. This study should foster further clinical diagnostics like tau- and amyloid-PET imaging as well as novel scientific approaches especially in basic research for further mechanistic proof.
Keyphrases
- pet imaging
- end stage renal disease
- stem cells
- ejection fraction
- newly diagnosed
- mesenchymal stem cells
- spinal cord
- magnetic resonance imaging
- oxidative stress
- prognostic factors
- cerebrospinal fluid
- contrast enhanced
- neuropathic pain
- computed tomography
- spinal cord injury
- pain management
- physical activity
- bone marrow
- multiple sclerosis
- positron emission tomography
- transcranial magnetic stimulation
- chronic pain